PMcardio
Overview
PMcardio, developed by Powerful Medical, is an AI-powered clinical assistant designed to digitize and interpret 12-lead electrocardiograms (ECGs). The platform is built for emergency physicians, general practitioners, cardiologists, paramedics, and nurses across diverse care settings, including emergency departments, ambulances, clinics, and hospital wards.
The tool integrates into clinical workflows by allowing providers to capture an image of any paper-based or digital 12-lead ECG using a smartphone. PMcardio’s AI models then analyze the image to detect over 50 distinct ECG findings, including arrhythmias, conduction blocks, and structural changes.
Notable Capabilities:
- STEMI and OMI Detection: The “Queen of Hearts” model identifies acute ST-elevation myocardial infarctions (STEMI) and occlusive myocardial infarctions (OMI).
- LVEF Screening: The “LVsense” model screens for reduced left ventricular ejection fraction (LVEF) directly from a standard ECG.
- Explainability Heatmaps: The “ECGxplain” feature visually highlights the specific leads and segments influencing the AI’s diagnostic predictions.
- Regulatory Status: PMcardio is certified as a Class IIb medical device under the EU Medical Device Regulation (MDR) and is registered with the UK MHRA. It has received FDA Breakthrough Device Designation for its STEMI AI model but is not yet cleared for marketing in the United States.
Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Key Features
- Instant AI-powered ECG interpretations
- Detection of 50+ ECG findings (including STEMI/OMI, rhythms, reduced LVEF, conduction disorders)
- Queen of Heartsu2122 - STEMI and OMI Detection
- LVsenseu2122 - Reduced LVEF Detection
- ECGxplainu2122 - Visual AI Explainability with heatmaps
- Core AI - Detects 36 core diagnoses (arrhythmias, conduction blocks, heart blocks, chamber hypertrophies)
- Automatic analysis of heart rate, axis, P wave, PR, QRS, and QT/QTc intervals
- Culprit Artery AI confidence scores with 3D heart visualization
- AI Confidence Scores for clinical decision-making
- Digitize and share ECG reports
Use Cases
- Rapid diagnosis at first patient contact
- Early detection of reduced Left Ventricular Ejection Fraction (LVEF)
- Detection of acute ST-elevation myocardial Infarction (STEMI) and STEMI-equivalent patterns
- Screening for structural heart disease
- Longitudinal monitoring of cardiac conditions
- Streamlining patient management and referral to cardiovascular specialists
What Physicians Need to Know
PMcardio can significantly enhance diagnostic confidence and efficiency, especially in acute care settings and primary care, by providing rapid, AI-powered ECG interpretations and guideline-adherent treatment recommendations. Its ability to detect subtle STEMI equivalents and reduced LVEF from ECGs can lead to earlier intervention and improved patient outcomes. For institutions, the platform offers integrated care coordination and real-time alerting, streamlining workflows and reducing false activations. While highly accurate for many conditions, be aware that its performance for signs of past or present ischemia might be more modest, and local calibration and prospective multicenter validation are important for widespread clinical implementation.
PMcardio is designed for enterprise-ready deployment, connecting to existing ECG devices, EHR/CVIS, EMS systems, angiographic systems, and communication tools. It supports seamless integration across hospital networks with a single integration, contract, and security review. The platform can be launched from the EHR with secure links and SSO, and it sends results back to clinical systems for documentation. PMcardio has also partnered with Roche to integrate AI-powered ECG interpretation into the cobasu00ae pulse point-of-care platform.
Details
| Category | Cardiology AI, Clinical Decision Support & Reference |
| Pricing |
Freemium
|
| Deployment | Mobile app (iOS and Android), Web platform, Enterprise integrations with EHR/CVIS and EMS systems |
| Compliance | |
| BAA Available | Unknown AI-estimated |
| HIPAA Compliant | Unknown AI-estimated |
| FDA Status |
Pending AI-estimated Powerful Medical's PMcardio STEMI AI ECG model has been granted Breakthrough Device Designation by the U.S. Food and Drug Administration (FDA). This designation recognizes it as a breakthrough technology for detecting ST-elevation myocardial infarction (STEMI) and STEMI equivalents, and provides an expedited review process towards market authorization. However, Powerful Medical technology has not yet been cleared by the US Food and Drug Administration (FDA) for marketing in the USA. |
| Integrations | |
| EHR | Not specified |
| Specialties | Cardiology, Emergency Medicine, Internal Medicine |
What the Web Says
PMcardio is an AI-powered medical device designed to assist healthcare professionals in interpreting 12-lead ECGs and diagnosing 38 cardiovascular diseases. It digitizes paper or screen-based ECGs and provides rapid, expert-level interpretations and guideline-adherent treatment recommendations. The app is CE-marked in Europe as a Class IIb medical device and has FDA Breakthrough Device Designation in the U.S., though it is not yet FDA-cleared for clinical decision-making in the US.
Overall: PositiveStrengths
- Highly accurate in diagnosing cardiovascular diseases, often outperforming general practitioners and even expert cardiologists in subtle cases.
- Saves time and money by providing rapid ECG interpretation and second opinions.
- Can digitize and improve damaged or distorted ECG tracings.
- Provides detailed treatment recommendations adhering to medical guidelines.
- User-friendly interface and compatible with any 12-lead ECG (image or paperform).
- Reduces false negative diagnoses of atrial fibrillation and myocardial infarctions, and can reduce false STEMI alarms.
Limitations
- Not yet FDA-cleared for clinical decision-making in the U.S.
- Some users reported inaccuracies, such as missing obvious ST elevation in continuous leads.
- Only works with 12-lead ECGs, not single-lead or Apple Watch ECGs.
- Can be expensive, and some users noted it was put behind a paywall.
- Occasional login and account issues reported by users.
- Diagnostic accuracy for indications of (past) ischemia was more modest in one study, with false-negatives potentially due to the algorithm's training in a higher-risk dataset.
Based on reviews from: Reddit, Product Hunt, Software Advice, Apple App Store, Powerful Medical (PMcardio website), YouTube (AI ECG App Review), Capterra, Google Play Store, PMcardio (AI vs MD ECG-Reading for Cath Lab Activation), PubMed Central (Diagnostic accuracy of the PMcardio smartphone application), GetApp, SGEM (Skeptics' Guide to Emergency Medicine), G2
Last updated: 2026-07-01
Ratings & Reviews
No reviews yet. Be the first to review this tool!
Rate PMcardio
Press & Coverage
Videos
Product demos, reviews, and walkthroughs for PMcardio.
How to Ensure Optimal ECG Upload in PMcardio for Individuals
Powerful Medical
PMcardio for Hospital Care (AI-powered ECG Digitization and Interpretation Platform)
Powerful Medical
PMcardio for Primary Care (AI-powered ECG Digitization and Interpretation Platform)
Powerful Medical
Powerful Medical: The AI revolution in cardiovascular care (Vision video)
Powerful Medical
Getting started with PMcardio - AI-powered ECG Digitization and Interpretation
Powerful Medical
PMcardio for Organization: AI-powered cardiovascular diagnostics and care-coordination
Powerful Medical
Frequently Asked Questions
Compare PMcardio
VS
VS
VS
VS
Investors who backed PMcardio
Funded through the company that built this tool.
